Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 in People Living With HIV: Evaluation of Risk Factors and Outcomes in Resource-limited Settings. A Pooled Substudy of ADVANCE, D²EFT, DolPHIN2 and NAMSAL

NCT04371835 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT04371835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04371835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 in People Living With HIV: Evaluation of Risk Factors and Outcomes in Resource-limited Settings. A Pooled Substudy of ADVANCE, D²EFT, DolPHIN2 and NAMSAL
Lead sponsor
Kirby Institute
Phase
Observational
Overall status
Completed
Start date
August 12, 2020
Completion date
December 31, 2021
Enrollment
596 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, hiv-infection/aids